Načítá se...
Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
Today, potential immunogenicity can be better evaluated during the drug development process, and we have rational approaches to manage the clinical consequences of immunogenicity. The focus of the scientific community should be on developing sensitive diagnostics that can predict immunogenicity-medi...
Uloženo v:
| Vydáno v: | J Immunol Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4942633/ https://ncbi.nlm.nih.gov/pubmed/27437405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1298473 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|